DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia

Abstract Background Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer....

Full description

Bibliographic Details
Main Authors: Guo‐Kang Sun, Li‐Juan Tang, Jing‐Dong Zhou, Zi‐Jun Xu, Lan Yang, Qian Yuan, Ji‐Chun Ma, Xing‐Hui Liu, Jiang Lin, Jun Qian, Dong‐Ming Yao
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Cancer Medicine
Subjects:
AML
Online Access:https://doi.org/10.1002/cam4.2540